STERIS (NYSE:STE) has a launched an enhanced version of a low-temperature sterilization system for surgical instruments.
The Mentor, Ohio, company received 510(k) clearance from the U.S. Food and Drug Administration in September for its new Amsco V-PRO maX Low Temperature Sterilization System.
The system offers three processing cycles to better accommodate a wide variety of surgical instruments, such as flexible endoscopes, cameras, batteries and cannulas, according to a statement from STERIS.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The system uses a 59 percent concentration of hydrogen peroxide to perform sterilization, which helps better prevent damage to instruments compared with sterilizers that use a higher concentration of the substance.
“The V-PRO maX benefits include potential gains in loading, processing and scheduling versatility, improved workflow speed and efficiency, and precedent-setting low-temperature sterile processing productivity,” said Renee Brown, product manager for the company’s infection prevention technologies division.
STERIS’ shares fell about 5 percent yesterday on heavy volume after the company announced that its second-quarter profits had fallen 17 percent.
